← All stories
Markets
Can Scancell (LSE:SCLP) Ride the Cancer Vaccine Momentum?
Highlights Cancer vaccine progress is drawing fresh attention to melanoma research. Scancell is advancing an off-the-shelf immunotherapy approach. Regulatory clearances are supporting preparations for a global late-stage study. Scancells me…
Covered by 1 outlet
All coverage · 1 article